Makary hints at his agenda

The confirmation of Marty Makary as FDA commissioner later this month will cap a tumultuous transition marked by internal upheaval and political infighting. At his confirmation hearing on March 6, Makary didn’t discuss the need to steady the agency, but he took care to project the image of a thoughtful, non-ideological leader who is unlikely to act rashly.

Makary steered clear of controversy, distanced himself from the chaotic personnel shakeups of the past six weeks, and barely mentioned the Make America Health Again (MAHA) movement that he has enthusiastically endorsed. ...